Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...
Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...
Pfizer (PFE) stock drops as company faces a federal probe on claims of delaying 2020 Covid vaccine success announcement for ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.
Tanner Smith was 14 when he was given a covid-19 vaccine without parental consent. Now North Carolina’s Supreme Court has ...
With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...